MedTrace Logo

Active Drainage vs. Passive Drainage in MRM

NCT07621575 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2026-06-02

No results posted yet for this study

Summary

The aim of the study is to compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in female patient with breast carcinoma as regard of:

Primary Outcomes:

1. Daily drain output (measured in mL/day).
2. Duration of the drain in place.
3. Amount of seroma aspiration after the drain removal.
4. Number of days till the last seroma aspiration.

Secondary Outcomes:

1. Flap necrosis.
2. Surgical site infection. 100 female divided into two equal groups:

* Group A: Active drainage group (50 patients).
* Group B: Passive drainage group (50 patients). After MRM ,drain output was measured daily using a graduated jar by nurse during hospital stay which was a one to two days in an average and then by patient himself. All the data was recorded on a paper sheet. In passive drain, breast and axilla outcomes were combined together as one read to be equal to one active drain gar. Twice per week, I checked this reading by myself and reported any complications).

Conditions

  • Modified Radical Mastectomy
  • Drain Effect
  • Seroma Formation
  • Brest Cancer

Interventions

PROCEDURE

compare active and passive drain

compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in in amount ,duration, respiration ,respiration duration ,SSI and skin necrosis

Sponsors & Collaborators

  • Kafrelsheikh University

    collaborator OTHER

  • MOHAMED GAMAL AHMED ARAKEEB

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-30
Primary Completion
2025-05-10
Completion
2025-11-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07621575 on ClinicalTrials.gov